Sanofi-Synthelabo's REACH Registry launched to increase knowledge of atherothrombosis

Published: 2004-01-27 06:56:00

Updated: 2004-01-27 06:56:00

Sanofi-Synthelabo announced recently the launch of the REACH (REduction of Atherothrombosis for Continued Health) Registry, one of the largest international registries ever conducted in people at risk of atherothrombosis, a life-threatening disease process that can lead to heart attack and stroke.

The registry is a survey that will document the health status and treatment of those at risk of...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.